Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis

Zuhal Filikci; Rikke Marie Jensen; Finn Thorup Sellebjerg

doi:10.1136/bcr-2022-250425

Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis

Zuhal Filikci^*, Rikke Marie Jensen, Finn Thorup Sellebjerg

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

1 Citation (Scopus)

14 Downloads (Pure)

Abstract

We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.

Original language	English
Article number	e250425
Journal	BMJ Case Reports
Volume	15
Issue number	11
ISSN	1757-790X
DOIs	https://doi.org/10.1136/bcr-2022-250425
Publication status	Published - 2022

Bibliographical note

Publisher Copyright:
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords

Multiple sclerosis
Neurology

Access to Document

10.1136/bcr-2022-250425Licence: CC BY-NC

FulltextFinal published version, 171 KBLicence: CC BY-NC

Cite this

@article{971b6f3ebc364c409a87995f9cbb931a,

title = "Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis",

abstract = "We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy. ",

keywords = "Multiple sclerosis, Neurology",

author = "Zuhal Filikci and Jensen, {Rikke Marie} and {Thorup Sellebjerg}, Finn",

note = "Publisher Copyright: {\textcopyright} BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2022",

doi = "10.1136/bcr-2022-250425",

language = "English",

volume = "15",

journal = "BMJ Case Reports",

issn = "1757-790X",

publisher = "BMJ Publishing Group",

number = "11",

}

TY - JOUR

T1 - Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis

AU - Filikci, Zuhal

AU - Jensen, Rikke Marie

AU - Thorup Sellebjerg, Finn

PY - 2022

Y1 - 2022

N2 - We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.

AB - We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.

KW - Multiple sclerosis

KW - Neurology

U2 - 10.1136/bcr-2022-250425

DO - 10.1136/bcr-2022-250425

M3 - Journal article

C2 - 36414352

AN - SCOPUS:85142515164

SN - 1757-790X

VL - 15

JO - BMJ Case Reports

JF - BMJ Case Reports

IS - 11

M1 - e250425

ER -